nome architecture. The 2.4 Gb of DNA comprising the haploid nuclear genome of the (female) domestic dog are partitioned into 38 pairs of acrocentric autosomes and two metacentric sex chromosomes ( Fig. 1 ) . The gross morphological similarity shared by many of the autosomes of the dog continues to present significant challenges to chromosome identification using conventional cytogenetics. The development of reagents and resources for molecular cytogenetic analyses of the canine genome has played a pivotal role in the generation of comprehensive and effective genome and comparative maps for the dog. Development and use of this molecular cytogenetics 'toolbox' allowed the development of a standardized chromosome nomenclature that led subsequently to the generation of integrated genome maps and played a key role in the anchoring of the canine genome assembly. In addition, molecular cytogenetics has allowed the gross genome architecture of the dog to be compared to other mammalian species and has also facilitated the development of means to assess genome changes associated with a variety of canine cancers. This article will review the development and application of these cytogenetic reagents and approaches.
Abstract. Humans and dogs have coexisted for thousands of years, during which time we have developed a unique bond, centered on companionship. Along the way, we have developed purebred dog breeds in a manner that has resulted unfortunately in many of them being affected by serious genetic disorders, including cancers. With serendipity and irony the unique genetic architecture of the 21st century genome of Man's best friend may ultimately provide many of the keys to unlock some of nature's most intriguing biological puzzles. Canine cytogenetics has advanced significantly over the past 10 years, spurred on largely by the surge of interest in the dog as a biomedical model for genetic disease and the availability of advanced genomics resources. As such the role of canine cytogenetics has moved
Development of a standard karyotype for the dog
The presence of 78 chromosomes in cells of the dog was determined by studies of meiotic cells (Minouchi, 1928) and later confirmed using cultured peripheral lymphocytes (Gustavsson, 1964) . The karyotype comprises 38 pairs of acrocentric autosomes, a large sub-metacentric X chromosome and a small metacentric Y chromosome ( Fig. 1 ) . Based on genome sequence data, the largest autosome, dog chromosome 1 (CFA 1) is ϳ 125 Mb in size (Lindblad-Toh et al., 2005) and is thus smaller than human chromosome 12, with all but the five largest dog chromosomes (CFA 1-5) being smaller in Mb size than human chromosome 18 ( Table 1 ) . Evaluation of unbanded chromosome preparations of the dog allows precise identification only for the sex chromosomes (due to their size and morphology) and chromosomes 1 and 38 (by virtue of their size). The gradual decrease in size of the remainder of the karyotype renders reliable recognition of conventionally stained homologous pairs almost impossible.
For many mammalian species, the development of chromosome banding techniques in the early 1970s provided the ability to identify homologous chromosome pairs and led to the subsequent development of internationally recognized chromosome numbering and banding nomenclatures. A variety of banded karyotypes for the dog have been published over the past 30 years and these are summarized in Table 2 . It became clear that, at least for many of the smaller dog autosomes, chromosome banding patterns alone did not offer sufficient discrimination to describe the complete karyotype of the dog with confidence. Consequently, to ensure consistency in chromosome description, a 'Committee Table 1 . Physical size of the chromosomes comprising the canine genome, derived from the earlier study of flow sorted chromosomes (Langford et al., 1996) and by the more recent canine genome sequence (Lindblad-Toh et al., 2005) 63  54  CFA 22  72  64  CFA 23  63  55  CFA 24  55  50  CFA 25  60  54  CFA 26  48  42  CFA 27  57  48  CFA 28  55  44  CFA 29  51  44  CFA 30  47  43  CFA 31  50  42  CFA 32  51  41  CFA 33  41  34  CFA 34  50  45  CFA 35  38  29  CFA 36  41  33  CFA 37  40  33  CFA 38  38  26  CFA X  137  126  CFA Y  27  -Total  2,782   a   2,424   a Total size of haploid female genome indicated.
for the Standardization of the Karyotype of the Domestic Dog' was established in the early 1990s under the auspices of the DogMap Workshop. This committee was charged with proposing a chromosome nomenclature of the dog karyotype that would be accepted on the international arena. Using conventional cytogenetics the committee was able to reach a consensus on the identification of dog chromosomes 1-21 (CFA 1-21), but concluded that a complete standardized karyotype would require the use of molecular cytogenetic reagents (Switonski et al., 1996) . Simultaneously, Langford et al. (1996) had used high-resolution bivariate flow sorting of dog chromosomes to generate a panel of whole chromosome paint probes (WCPP) for fluorescence in situ hybridization (FISH) analysis of the dog. These WCPP provided the essential common resource to members of the committee, and the joint efforts of many researchers led subsequently to the development of a consensus chromosome nomenclature for CFA 21-38 (Breen et al., 1998) . The combined chromosome numbering system of all chromosomes of the dog that was proposed by the committee (Switonski et al., 1996; Breen et al., 1998 Breen et al., , 1999 was later endorsed by the 'International Society of Animal Genetics' (ISAG) DogMap workshop held in Minneapolis, July 2000. At that time, the physical size of each dog chromosomes was estimated by inference from bivariate-chromosome sorting with mixtures of human and dog chromosomes (Langford et al., 1996; Breen et al., 1999) and suggested that the haploid genome of a female dog was in the region of 2,800 Mb ( Table 1 ). It is interesting to note that while the dog karyotype was initially assembled based on conventional microscopic assessment of chromosome size, we know now that the actual physical sizes of the dog chromosomes bear little resemblance to their order in the established karyotype. Despite the introduction of a more sophisticated means of identification, the initial ordering of the karyotype was left as was and so the continued use of more sophisticated tools is still essential for reliable dog chromosome identification.
The introduction of canine molecular cytogenetics
The generation of whole chromosome paint probes and larger insert genomic libraries (bacteriophage and cosmid) saw the introduction of canine molecular cytogenetics. Simultaneously, the development of sophisticated cooled charged coupled device cameras, refinement of fluorescence filter band widths and the introduction of advanced multi-plane imaging software facilitated the development of multicolor FISH analysis. As a consequence more laboratories began to adopt fluorochrome based banding techniques (e.g. DAPI banding) to allow concurrent chromosome identification during FISH analyses, rather than the need to perform pre-or post hybridization chromosome banding. Sequential chromosome painting analysis with fluorescently labeled chromosome paint probes (Langford et al., 1996) onto single metaphases produced a series of complete DAPI banded karyotypes of the dog in which the chromosome numbering followed that adopted by the standardization committee . To allow accurate assignment of FISH mapped single locus probes (SLPs) to DAPI banded dog chromosomes, a 460-band ideogram of the dog karyotype with five grey levels was also produced .
Independently, a second set of dog chromosome paint probes was generated (Yang et al., 1999 ) and a detailed comparative chromosome painting approach (dog vs. red fox vs. human chromosomes) was applied in order to identify the dog chromosomes indirectly. The authors were able to integrate their chromosome nomenclature with that of the standardization committee for all but ten of the smaller autosomes (Graphodatsky et al., 2000) . These ten discrepancies are shown in Table 3 . A second DAPI banding pattern for the whole karyotype of the dog was generated in the form of a black and white ideogram. The nomenclature of the standardization committee was subsequently used to define the chromosomes in the 7.6! canine genome assembly (Lindblad-Toh et al., 2005) and so use of the nomenclature proposed by Yang et al. (1999) , which has been used subsequently by Graphodatsky et al. (2000) , requires numerical conversion of these ten autosomes to be compliant with the genome assembly data. CFA 1-21 were defined by the use of whole chromosomes paint probes generated by Langford et al. (1996) , with the chromosome numbering based on Selden et al. (1975) . b CFA 22-38 were defined by the whole chromosomes paint probes generated by Langford et al. (1996) and ordered according the recommendation of the 'Committee for the Standardization of Dog Karyotype'. c All chromosomes were defined by the use of whole chromosomes paint probes generated by Langford et al. (1996) and ordered according the recommendation of the 'Committee for the Standardization of Dog Karyotype'.
The role of canine molecular cytogenetics in genome mapping
Following the establishment of a standardized chromosome nomenclature, the use of multicolor FISH technology in canine genomics opened the door to expedite the physical mapping of numerous clones that contained key elements of emerging genome maps. In the first integrated genome map of the dog (Breen et al., 2001) , 266 cosmid clones, each containing a polymorphic microsatellite marker, were used as chromosome-specific single locus probes (SLPs) to define their cytogenetic location. Distributed across all chromosomes these clones thus served as key cytogenetic points and enabled the 1,800 marker integrated meiotic/radiation hybrid (RH) map of the canine genome (Breen et al., 2001) as well as the subsequent 3,279 marker (Guyon et al., 2003) and 4,249 marker (Breen et al., 2004 ) RH maps of the dog to be firmly anchored to the karyotype. At the cytogenetic level, this 4,249 RH map reported the precise location of 1,000 canine bacterial artificial chromosome (BAC) clones (see below), each of which had been ordered along the length of each chromosome using stepwise multicolor SLP analysis. Of these 1,000 BAC clones, 804 were in common with the RH map. The use of a common set of markers for both the cytogenetic and the RH maps ensured that the integrated map was firmly anchored at multiple locations along the length of each chromosome, providing a very high level of confidence in marker order for this and the subsequent 10,000 marker RH map (Hitte et al., 2005) . Molecular cytogenetics played a valuable role in anchoring the 7.6! genome assembly; indirectly via the use of cytogenetically-anchored RH map data as a means to provide useful ordering information, and directly as a tool to determine the precise location of sequences directly on chromosomes.
The development of additional reagents to enhance the growing canine molecular cytogenetics 'toolbox' became available with the development of two BAC libraries. The first, RPCI-81 (Li et al., 1999) was constructed from a male Doberman Pinscher and represents 8.1! genome coverage with an average insert size of 155 kb (http://bacpac.chori. org/mcanine81.htm). Numerous groups have used this library as a source of large insert genomic clones that have been used as SLPs to determine the precise cytogenetic location of many loci within the canine genome. In addition to the ϳ 1,000 clones mapped as part of the development of the canine RH-map (Breen et al., 2004) numerous BACs were selected by screening the library specifically to obtain clones containing genes of interest. Many of these clones, which were FISH mapped to determine their cytogenetic location, contained genes associated with disease (e.g. van de Sluis et al., 1999 Sluis et al., , 2001 Wagner et al., 1999; Thomas et al., 2001a; Lozier et al., 2002; Rak et al., 2002 Rak et al., , 2003 van den Berg et al., 2003 van den Berg et al., , 2004 Wagner, 2003; Klukowska et al., 2004a, b; Stabej et al., 2004 Stabej et al., , 2005 Debenham et al., 2005; Philipp et al., 2005 ; also see http://faculty.vetmed.ucdavis. edu/Faculty/lalyons/Sites/CompGenBACsDOG.htm) and cancer (Thomas et al., 2003a, b) . Additional clones from the RPCI-81 library have been used as an aid to visualize comparative genome organization (e.g. Yudkin et al., 2007) .
Specifically for molecular cytogenetic studies, clones from the RPCI-81 BAC library have been used to generate panels of chromosome-specific FISH probes. A set of 41 clones was described by Thomas et al. (2003c) that may be used to identify conclusively each dog chromosome according to the position of each clone on the corresponding chromosome. Also from this library, a panel of 80 BAC clones was assembled in groups of 1-3 clones per dog autosome that, when labeled/detected with one of five fluorochromes in a single hybridization, is reported to identify simultaneously all dog chromosomes within a metaphase spread (Courtay-Cahen et al., 2007) . Both these chromosome-specific panels are useful for identifying chromosomes that are considered structurally normal. As such, these panels may be used for chromosome identification following metaphase-based comparative genomic hybridization (CGH) analysis. As part of the cytogenetic anchoring of dog RH maps, over 1,000 BAC clones from the RPCI-81 library were cytogenetically assigned using multicolor FISH analysis and details of each assignment were reported (Breen et al., 2004) (http://www.cvm.ncsu.edu/mbs/ breen/dog_map.htm). Using these clones, Thomas et al. (2005) generated a genome-wide BAC microarray, with ϳ2 Mb resolution and demonstrated how this array may be used for detecting copy number changes in canine cancers using array comparative genomic hybridization (see below). Use of a cytogenetically characterized array overcomes the need for identification of individual dog chromosomes and allows for a much greater throughput of cases.
Genome integrated canine cytogenetics -band to base pair
A second dog BAC library, CHORI-82, was constructed from a female Boxer, 'Tasha', the same female whose DNA was used to generate the 7.6! canine genome assembly (http://bacpac.chori.org/library.php?id=253). This library Table 3 . Dog chromosome nomenclature differences between the studies of Breen et al. (1999) and Yang et al. (1999 Yang et al. (1999)   25  28  27  29  28  31  29  34  30  25  31  27  33  30  34  35  35  37  37  33 represents 10! coverage of the canine genome and contains ϳ 198,000 clones with an average insert size of 172 kb. As part of the development of the 7.6! canine genome sequence, BAC end sequences were generated from the clones comprising this library and so the library represents a valuable cytogenetics resource of genome assembly-integrated clones. Using web-based resources such as the UCSC Genome Browser (http://genome.ucsc.edu/cgi-bin/ hgGateway) CHORI-82 clones may be selected, based either on their position within the genome or their specific gene/sequence content, and used as SLPs in FISH analysis. Using this process chromosome tiling sets of arrays have been generated with clone spacing at 10 Mb resolution (Thomas et al., 2007) and 1 Mb resolution (Thomas et al., submitted) .
In molecular cytogenetics of any species the accepted resolution of metaphase FISH is in the region of 2-4 Mb, assuming that the chromosome spreads are elongated and the probe signals are discrete. In general the more common use of mid-metaphase preparations reduces this resolution to approx 4-6 Mb and so precise ordering of clones that are spaced by smaller distances requires the use of interphase FISH analysis ( Fig. 2 ) . In developing the genome wide, assembly-integrated BAC panels, Thomas et al. (submitted) were able to determine that over 95% of the 2,122 clones mapped by FISH did so with a unique cytogenetic location and to the region of the chromosome indicated by the genome assembly. This figure lends high confidence to the structural integrity of the assembled genome and confidence to selecting clones from the genome browsers.
As with other species, the availability of BAC clones that are integrated into the genome assembly launched canine molecular cytogenetics into a new arena -observations of microscopically visualized chromosome aberrations may be rapidly translated to aberrations of specific regions of the genome sequence. With this in mind, genome integrated canine BAC arrays have been developed with the panels of genome-anchored BACs described above. The first is a genome-wide BAC array comprising 275 clones spaced at intervals of approximately 10 Mb and also contains clones representing the dog orthologues of 31 genes implicated in human cancers (Thomas et al., 2007) . This array has been shown to be of use for first pass assessment of gross genome-wide DNA copy number variation in canine tumors and provides a similar resolution to that produced by metaphase based CGH analysis, albeit without the need to be able to identify the dog chromosomes. A higher resolution genome-wide array has also been generated which contains 2,122 clones and represents a typical resolution of ϳ 1 Mb (Thomas et al., submitted) . In both cases, each clone included on the array has been used as an SLP to verify that it a) has a unique cytogenetic location and b) maps to the chromosome region indicated by the assembly. The results of this study indicated that, with a few exceptions, the 7.6! canine genome assembly is able to act as a robust source of CHORI-82 clones that may be used for canine cytogenetics.
Canine cytogenetics and evolution
The domestic dog belongs to the Canidae, a family that is believed to have diverged from other carnivore families ϳ 50-60 million years ago. Within the extant Canidae, divergence from a common ancestor is reported to have commenced ϳ 7-10 million years ago (Wayne, 1993) . Previous studies indicated that the family is divided into two major groupings, the 'dog-like' and 'fox-like' canids (BinindaEmonds et al., 1999; Graphodatsky et al., 2001 ). More recent genetic data, including data generated as part of the dog genome sequence project (Lindblad-Toh et al., 2005) , have suggested that the family may be refined into four major phylogenetic groups represented by the fox-like canids (including the racoon dog), the gray and island fox species, the South American canids and the wolf-like canids (including the domestic dog) (Ostrander, 2007) . Cytogenetic studies of the 34 extant species comprising the Canidae have revealed considerable variation in chromosome number and morphology. The karyotype architecture of the Canidae ranges from 2n = 34 in the red fox ( Vulpes vulpes ) to 2n = 78 in the wolflike canids, including the domestic dog ( Canis famili aris ) (Wayne, 1993) . Canid karyotypes with lower chromosome numbers contain numerous bi-armed autosomes, while the autosomes of the wolf-like canids are all acrocentric. The family has thus undergone a relatively high rate of karyotype evolution and offers an exciting opportunity to use detailed cytogenetic evaluation, with both conventional and molecular approaches, to assess chromosomal evolution.
Whole chromosome reciprocal chromosome painting and comparative chromosome banding have been performed on numerous species within the Canidae. In addition to the domestic dog (2n = 78) these studies have primarily involved the fox-like canids such as the Red Fox , and Arctic Fox ( Alopex lagopus , 2n = 48-50). These studies suggest an apparent gross pattern of whole-arm rearrangements during speciation within the Canidae (Yang et al., 1999; Graphodatsky et al., 2000 Graphodatsky et al., , 2001 Nie et al., 2003) . Notable exceptions to the presence of single segment shuffling was evident for dog chromosomes 1, 13 and 19, each of which corresponds to two chromosome segments of the Red Fox, Raccoon dog and Arctic Fox, and while dog chromosome 18 is represented by a single conserved segment in the Raccoon Dog, it also is split across two segments in the Red Fox and Arctic Fox (Graphodatsky et al., 2000 (Graphodatsky et al., , 2001 ).
An interesting feature of the karyotypes of several species within the Canidae is the presence of B chromosomes, supernumerary chromosomes within a karyotype that may vary in their number and have been described in a wide range of species, primarily plants and insects (Jones, 1975; Jones and Diez, 2004) . The role of B chromosomes and their variability in number is still unknown, though in some nonmammalian species it has been suggested that B chromosome numbers may contribute to the formation of aberrant meiotic products (Camacho et al., 2000 (Camacho et al., , 2004 . Early studies of B chromosomes in the Raccoon dog indicated that they were composed of telomeric-like sequences (Wurster-Hill et al., 1988) , while more recent studies indicated the presence of nucleolar organizer region (NOR)-like sequences . B chromosomes of the red fox, however, have been shown to be rich in centromericlike sequences (Yang et al., 1999) . FISH analysis, using chromosome paints and/or single locus probes has suggested that canid B chromosomes may share ancestry with small ( ! 1 Mb) autosomal DNA segments and thus contain active genes (Trifonov et al., 2002; Graphodatsky et al., 2005; Yudkin et al., 2007) . A more detailed assessment of the genome organization of these supernumerary chromosomes will be needed to further evaluate their potential significance. The dog genome sequence will undoubtedly play a key role in furthering these studies by providing a common reference point for the other canids.
Comparative maps from a wide range of mammalian species are providing key information about the dynamics of chromosome evolution (Murphy et al., 2005) . For example, cytogenetic resources developed for the dog have also played a role in extending comparative cytogenetics beyond the Canidae by expanding cross-species painting studies to include members of the Felidae and Ursidae, both of which also belong to the order Carnivora (Tian et al., 2004) .
Canine clinical cytogenetics and cancer
The presence of gross cytogenetic changes in non-neoplastic cells has been reported only rarely in the domestic dog. The most common chromosome abnormality reported in non-cancer specimens involves the sex chromosomes. Almost two decades ago, conventional cytogenetics was used to investigate dogs with sexual development disorders and revealed that several possessed X chromosome aneuploidy (79,XXY) or were chimeras (78,XX/78,XY) (reviewed by Mellink and Bosma, 1989) . In addition infertile bitches have been shown, using both conventional cytogenetic and molecular cytogenetics, to present with X chromosome aneuploidy (Schelling et al., 2001; Switonski et al., 2003a, b) . Molecular cytogenetic analysis of dogs presenting Duchenne muscular dystrophy (DMD) revealed that, as in humans, such cases presented with a small deletion of a region of Xp21, containing the canine DMD gene (Schatzberg et al., 1999) . The availability of high-resolution cytogenetic resources for the dog will allow a more detailed evaluation of more subtle changes in dogs with unusual syndromes.
Clonal chromosome aberrations have been described in almost 27,000 human neoplasms that collectively represent approximately 75 different types of cancer (http://cgap.nci. nih.gov/Chromosomes/Mitelman). There is broad acceptance that the accurate identification of recurring chromosome abnormalities in malignant cells provides opportunities to increase the sophistication of diagnosis, sub-classification and prognosis of neoplastic disorders. In human medicine, the identity of cytogenetic aberrations has been shown to also assist in the localization of cancer-associated genes and even selection of the most appropriate therapeutic approach. The application of molecular cytogenetics to the analysis of human neoplasia has revolutionized the way in which we interrogate tumor cells for cytogenetic changes, whether they are numerical or structural in nature.
Veterinary medicine has provided a wealth of information about the clinical and pathological presentation of numerous canine cancers. Despite millions of years of divergent evolution, the high degree of similarity between human and dog also extends to their genome sequences (LindbladToh et al., 2005) . As pets, dogs (and thus their genomes) are exposed to the same environmental influences as humans. It is not surprising therefore that there are considerable pathophysiological similarities shared by many forms of human and canine cancer (Withrow and Vail, 2006) . In addition, the demographic history and genetic structure of many purebred domestic dogs has resulted in the development of distinct genetic isolates or breeds, which have been shown to have highly reduced levels of genetic variation and specific association with genetic disease (Ostrander and Giniger, 1997; Ostrander and Kruglyak, 2000; Parker et al., 2004; Sutter and Ostrander, 2004; Ostrander, 2007) . In terms of cancer incidence, it is well known that purebred dog breeds are associated with differing susceptibility to specific malignancies (Priester and McKay, 1980; Patterson, 2000; Modiano et al., 2005) . Such breed-associated predisposition suggests that selected breeds of dog are inheriting 'at risk' alleles for very few genes, perhaps even a single gene, with a profound effect. These features, combined with the sophisticated genomic resources now available for the dog, have placed the dog in a position of high visibility as a model system for cancer research.
The combination of pathophysiological and genetic similarity shared between human and dog led to the hypothesis that canine tumors may contain the natural variety of chromosome aberrations that are observed in human cancers, a feature that is not evident with induced rodent tumors. Molecular cytogenetic studies of canine cancers have demonstrated that this is indeed the case. For example, in studying canine hematopoetic malignancies it has been shown that cells isolated from human and dog tumors of comparable malignancies share several evolutionarily conserved cytogenetic changes (Thomas et al., 2003c; Breen and Modiano, 2008) . As is the case in human cancers, a detailed cytogenetic investigation of canine tumors may therefore reveal the identity of recurrent changes that are of diagnostic and/ or prognostic significance. To further this concept, evaluation of cytogenetic changes in canine tumors has been performed using a combination of direct cytogenetic analysis of tumor karyotypes from individual cells, using both conventional and molecular cytogenetics and indirect analysis using DNA from the tumor cell population in comparative genomic hybridization.
Direct analysis -chromosome paints and single locus probes
The difficulties associated with identification of normal dog chromosomes (see above) are exacerbated when such chromosomes undergo structural changes and so evaluation of complex canine tumor karyotypes using G-banding or DAPI banding alone is not a realistic option. While there were numerous early studies aimed at evaluating chromosome changes in canine cancers, the limitations of using chromosome banding techniques were very evident. Consequently, early conventional cytogenetic analyses of canine cancer karyotypes were generally restricted to very few cases. Further, while such reports were able to describe the presence of additional chromosomes and/or aberrant chromosome structures, they were unable to identify conclusively which chromosomes were involved in the aberration (Basrur and Gilman, 1966; Whang-Peng, 1969; Miles et al., 1970; Idowu, 1976; Grindem and Buoen, 1986; Mayr et al., 1990 Mayr et al., , 1992 . The development of molecular cytogenetics reagents for the dog, however, permits detailed direct analysis of canine tumor genomes by FISH analysis. The use of chromosome paint probes and/or cytogenetically characterized single locus probes allows a rapid assessment of the gross numerical and structural characteristics of chromosomes within individual tumor cells. Chromosome painting analysis is widely used to unravel the complex nature of chromosome rearrangements and to determine chromosomal organization in the karyotypes of human cancers and syndromes (see for example, Blennow, 2004; Langer et al., 2004) . The availability of high quality chromosome paints for application to canine tumor cytogenetics (Langford et al., 1996; Yang et al., 1999) has enabled this approach to be used similarly in the investigation of karyotypic abnormalities in canine tumors including mammary carcinoma (Tap et al., 1998) , lymphoma (Thomas et al., 2001b) and soft tissue sarcoma (Milne et al., 2004) . The development of multiplex-FISH (M-FISH) (Speicher et al., 1996) and spectral karyotyping (Schrock et al., 1996) for human cytogenetics has led to many new cytogenetic discoveries over the past decade due to their ability to increase the amount of genomic data that can be generated in a single experiment. To identify all 40 chromosome types (38 autosomes + X + Y) of the dog in a single FISH reaction with different colors, i.e. 40 color M-FISH, would require the use of six spectrally resolvable fluorochromes, which is beyond the scope of many laboratories. To overcome this limitation, Milne et al. (2004) used a robust seven-color system in their study of canine sarcomas and established karyotype coverage over a series of six different separate FISH reactions.
Though of broad use, chromosome paint probes generated for the dog have not been widely available. To overcome this, panels of cytogenetically verified chromosome-specific single locus probes have been generated as described above (Thomas et al., 2003c (Thomas et al., , 2007 Courtay-Cahen et al., 2007) . Since these SLP panels are generated from commercially available canine BAC libraries, and the identity of each clone used is publicly available, it is a simple process for any cytogenetics laboratory to purchase these clones and generate their own SLP panels. The most recent of these chromosome-specific SLP panels was generated by selection of clones from the canine genome assembly (see above) and offered an opportunity to tile aberrant chromosomes in tumor karyotypes and refine the precise region of chromosome breakpoints in tumor karyotypes beyond the resolution possible with chromosome paint probes (Breen and Modiano, 2008) .
Indirect analysis -comparative genomic hybridization
Comparative genomic hybridization (CGH) is a molecular cytogenetic approach to screen an entire genome for regions of copy number aberration (CNAs) in a single experiment (Kallioniemi et al., 1992 (Kallioniemi et al., , 1994 . Metaphase-based CGH was used to identify CNAs in a range of human malignancies including cancers of the brain (Petersen et al., 2000; Wiltshire et al., 2000; Scheil et al., 2001) , prostate (Cher et al., 1994) , breast (Tirkkonen et al., 1998; Rodriguez et al., 2000) , bladder (Obermann et al., 2003) , thyroid (Wreesmann et al., 2002) , skin (Bastian et al., 1998) and hematopoetic system (Allen et al., 2002; Berglund et al., 2002; Franke et al., 2002) . Chromosome-based CGH was developed for application to canine tumors (Dunn et al., 2000; Thomas et al., 2001b) and has been used to demonstrate that recurrent chromosome aberrations are present in canine lymphoma (Thomas et al., 2003c) . However, as with other species, canine metaphase-based CGH presents two key limitations to high throughput: 1) the approach requires conclusive identification of dog metaphase chromosomes, necessitating a secondary analysis with chromosome specific SLPs (Dunn et al., 2000; Thomas et al., 2003c; CourtayCahen et al., 2007) ; 2) the use of metaphase chromosomes as the target limits the ability to detect copy number changes to those that are generally greater than 5-10 Mb (Pinkel et al., 1998; Lichter et al., 2000) .
The recent development of microarray-based CGH (aCGH) analysis overcomes many of the limitations of conventional metaphase-based CGH, offering increased resolution that is dependent solely on clone spacing. Array CGH has been used to describe a wide variety of DNA copy number changes in human cancers, providing a new and valuable insight into the underlying gene involvement of tumors (e.g. Bejjani and Shaffer, 2006; Shaffer and Bejjani, 2006; Gunn et al., 2007) . Array-based CGH analysis has been developed for application to the dog, based on the use of degenerate-oligonucleotide-primed PCR products from canine BAC clones, each of which has been assigned to a precise cytogenetic location using FISH analysis (see above). Preliminary use of these arrays, as shown in Fig. 3 , has demonstrated that for canine cytogenetics this approach offers an exciting opportunity for significant improvement in resolution as well as throughput of canine cancer specimens (Thomas et al., 2007 and submitted) . The use of integrated BAC arrays allows rapid translation from cytogenetic aberrations to genome sequence aberrations. In combination with reliable clinical and pathological data of canine cancer patients, canine cytogenetics should therefore develop an Fig. 3 . Whole genome aCGH profile of a canine tumor. These data were obtained using a 1 Mb assembly-integrated dog BAC array (Thomas et al., submitted) . Data are plotted as the median, block-normalized and background-subtracted log 2 ratio of replicate spots for each of 2,122 BAC clones on the 1 Mb array. Log 2 ratios representing genomic gain and loss are indicated by horizontal bars above (thin green line) and below (thin red line) the midline representing normal copy number. Using the aCGH Smooth algorithm (Jong et al., 2004) , the chromosome copy-number status line appears as orange where no major genomic imbalances were apparent and as either red or green in regions where genomic imbalances were apparent (red = loss, green = gain). This profile indicates whole chromosome loss for CFA 17 and CFA 34. In addition there are several additional copy number aberrations of isolated clones. Validation of these inferred copy number changes is verified by using the BAC clones on the array to perform single locus probe analysis of the tumor cells. This process provides a means to assess that distribution of locus copy number within the actual tumor cell population (as shown in Fig. 4 ) . Fig. 4 . SLP analysis of a canine tumor. The data revealed dual monosomy and indication of a translocation event. In Fig. 3 , the aCGH data indicated a DNA copy number loss for CFA 17 and 34. Five BAC clones were used to generate multicolor single locus probe data for this case including a clone each of CFA 17 (purple) and CFA 34 (green) and two clones spaced at 1Mb on CFA 20. ( a ) Co-hybridization of these five clones to an interphase nucleus from a normal canine cell, demonstrating the presence of a normal copy number (n = 2) for each of the five clones and also the close association of the two clones from CFA 20 (shown in aqua and yellow). ( b ) Co-hybridization of the same five BAC clones to an interphase nucleus of a cell from the tumor profiles in Fig. 3 revealed that while three of the five probes had normal (n = 2) copy number (red, yellow and aqua), the two probes representing CFA 17 (purple) and CFA 34 (green) were present as one copy, confirming the copy number loss of these two chromosomes indicated by the aCGH profile in a . In addition, the two clones on CFA 20 (yellow and aqua) are now no longer closely associated in this tumor cell, indicating the presence of chromosome break in the 1 Mb interval between these two clones.
approach that will provide help to establish more accurate classification of canine tumors and so advance our aim to enhance the clinical management of our pet dogs.
The availability of a high density genome wide, genome integrated, cytogenetically characterized panel of canine BAC clones also provides the basis for the selection of clones for use in the characterization of both numerical and structural chromosomal changes associated with cancers. Individual clones may be used to determine DNA copy number variations within tumor cell populations and pooled clones may be used to visualize karyotype reassembly presenting in such cells ( Fig. 4 ) . The identity of recurrent cytogenetic changes in canine cancers should lead to the discovery of those changes that are associated with diagnosis and prognosis and thus open the door for clinical cytogenetics to become a routine component of the clinical management of dogs presenting with cancers.
Summary
The use of genome-integrated cytogenetic resources such as those described above have advanced canine cytogenetics to a stage that will allow a much more detailed evaluation of mammalian chromosomal evolution. Simultaneously the field has reached a point where aberrant chromosomal regions may be translated to specific regions of the canine genome and may identify genes of significance in canine cancers. As with human patients, we anticipate that new therapies offered for our pet dogs will become available. The ability to characterize response-associated cytogenetic changes will be a valuable aid to the refinement of prognosis and thus the clinical management of patients.
The pathophysiological and genome similarities between dog and human cancers may also lead to genes being discovered in studies of canine cancers that are also of major significance in human cancers. It seems that the unique bond shared between human and dog extends now beyond one with an emotional basis; it is now a bond that is at least in part fortified by the biomedical relationship that we share. For thousands of years the bark of our dogs has provided an early warning system for our safety. In the 21st century that role may extend, with studies of the canine genome aiding our development of early warning systems for our health. The domestic dog and now its genome, quite rightly, continue to be Man's best friend.
